Nonprescription drugs: considering a new class for behind-the-counter drugs
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York
Nova Science Publishers
c2010
|
| Schriftenreihe: | Pharmacology-research, safety testing, and regulation series
|
| Schlagworte: | |
| Beschreibung: | Includes bibliographical references and index |
| Beschreibung: | viii, 199 p. |
| ISBN: | 9781614704386 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044088855 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 170217s2010 |||| o||u| ||||||eng d | ||
| 020 | |a 9781614704386 |c Online |9 978-1-61470-438-6 | ||
| 035 | |a (ZDB-30-PAD)EBC3020570 | ||
| 035 | |a (ZDB-89-EBL)EBL3020570 | ||
| 035 | |a (OCoLC)839305329 | ||
| 035 | |a (DE-599)BVBBV044088855 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 615/.1 |2 22 | |
| 245 | 1 | 0 | |a Nonprescription drugs |b considering a new class for behind-the-counter drugs |c Lars P. Eliassen, editor |
| 264 | 1 | |a New York |b Nova Science Publishers |c c2010 | |
| 300 | |a viii, 199 p. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Pharmacology-research, safety testing, and regulation series | |
| 500 | |a Includes bibliographical references and index | ||
| 505 | 0 | |a Nonprescription drugs : considerations regarding a behind-the-counter drug class / Government Accountability Office -- Food and Drug Administration behind the counter availability of certain drugs, public meeting / United States Department of Health and Human Services | |
| 650 | 4 | |a Politik | |
| 650 | 4 | |a Drugs, Nonprescription |x Government policy |z United States | |
| 651 | 4 | |a USA | |
| 700 | 1 | |a Eliassen, Lars P. |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 978-1-60741-961-7 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 1-60741-961-0 |
| 912 | |a ZDB-30-PAD | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029495700 | ||
Datensatz im Suchindex
| _version_ | 1804177140519796736 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV044088855 |
| collection | ZDB-30-PAD |
| contents | Nonprescription drugs : considerations regarding a behind-the-counter drug class / Government Accountability Office -- Food and Drug Administration behind the counter availability of certain drugs, public meeting / United States Department of Health and Human Services |
| ctrlnum | (ZDB-30-PAD)EBC3020570 (ZDB-89-EBL)EBL3020570 (OCoLC)839305329 (DE-599)BVBBV044088855 |
| dewey-full | 615/.1 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.1 |
| dewey-search | 615/.1 |
| dewey-sort | 3615 11 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01587nmm a2200385zc 4500</leader><controlfield tag="001">BV044088855</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170217s2010 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781614704386</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-61470-438-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PAD)EBC3020570</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL3020570</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)839305329</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044088855</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.1</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Nonprescription drugs</subfield><subfield code="b">considering a new class for behind-the-counter drugs</subfield><subfield code="c">Lars P. Eliassen, editor</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Nova Science Publishers</subfield><subfield code="c">c2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">viii, 199 p.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Pharmacology-research, safety testing, and regulation series</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Nonprescription drugs : considerations regarding a behind-the-counter drug class / Government Accountability Office -- Food and Drug Administration behind the counter availability of certain drugs, public meeting / United States Department of Health and Human Services</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Politik</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs, Nonprescription</subfield><subfield code="x">Government policy</subfield><subfield code="z">United States</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Eliassen, Lars P.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">978-1-60741-961-7</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">1-60741-961-0</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PAD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029495700</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV044088855 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:43:21Z |
| institution | BVB |
| isbn | 9781614704386 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029495700 |
| oclc_num | 839305329 |
| open_access_boolean | |
| physical | viii, 199 p. |
| psigel | ZDB-30-PAD |
| publishDate | 2010 |
| publishDateSearch | 2010 |
| publishDateSort | 2010 |
| publisher | Nova Science Publishers |
| record_format | marc |
| series2 | Pharmacology-research, safety testing, and regulation series |
| spelling | Nonprescription drugs considering a new class for behind-the-counter drugs Lars P. Eliassen, editor New York Nova Science Publishers c2010 viii, 199 p. txt rdacontent c rdamedia cr rdacarrier Pharmacology-research, safety testing, and regulation series Includes bibliographical references and index Nonprescription drugs : considerations regarding a behind-the-counter drug class / Government Accountability Office -- Food and Drug Administration behind the counter availability of certain drugs, public meeting / United States Department of Health and Human Services Politik Drugs, Nonprescription Government policy United States USA Eliassen, Lars P. Sonstige oth Erscheint auch als Druck-Ausgabe, Hardcover 978-1-60741-961-7 Erscheint auch als Druck-Ausgabe, Hardcover 1-60741-961-0 |
| spellingShingle | Nonprescription drugs considering a new class for behind-the-counter drugs Nonprescription drugs : considerations regarding a behind-the-counter drug class / Government Accountability Office -- Food and Drug Administration behind the counter availability of certain drugs, public meeting / United States Department of Health and Human Services Politik Drugs, Nonprescription Government policy United States |
| title | Nonprescription drugs considering a new class for behind-the-counter drugs |
| title_auth | Nonprescription drugs considering a new class for behind-the-counter drugs |
| title_exact_search | Nonprescription drugs considering a new class for behind-the-counter drugs |
| title_full | Nonprescription drugs considering a new class for behind-the-counter drugs Lars P. Eliassen, editor |
| title_fullStr | Nonprescription drugs considering a new class for behind-the-counter drugs Lars P. Eliassen, editor |
| title_full_unstemmed | Nonprescription drugs considering a new class for behind-the-counter drugs Lars P. Eliassen, editor |
| title_short | Nonprescription drugs |
| title_sort | nonprescription drugs considering a new class for behind the counter drugs |
| title_sub | considering a new class for behind-the-counter drugs |
| topic | Politik Drugs, Nonprescription Government policy United States |
| topic_facet | Politik Drugs, Nonprescription Government policy United States USA |
| work_keys_str_mv | AT eliassenlarsp nonprescriptiondrugsconsideringanewclassforbehindthecounterdrugs |